Guardant Health
GH
#1336
Rank
A$24.33 B
Marketcap
A$183.54
Share price
-2.43%
Change (1 day)
143.71%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of March 2026 : A$2.43 Billion

According to Guardant Health 's latest financial reports the company's total debt is A$2.43 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$2.55 B18.87%
2024-12-31A$2.14 B8.1%
2023-12-31A$1.98 B-1.25%
2022-12-31A$2.01 B6.19%
2021-12-31A$1.89 B70.51%
2020-12-31A$1.11 B1826.05%
2019-12-31A$57.69 M
2018-12-31N/A-100%
2017-12-31A$0.84 M-96.43%
2016-12-31A$23.63 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Neogen
NEOG
A$1.13 B-53.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A$0.34 B-85.92%๐Ÿ‡บ๐Ÿ‡ธ USA